This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Valeant Canada Ltd.
Valeant Canada Ltd., a prominent player in the pharmaceutical and biotechnology industry, is headquartered in Canada. Founded in 1960, the company has established itself as a leader in specialty pharmaceuticals, focusing on dermatology, ophthalmology, and neurology. With a strong presence in North America and expanding operations in international markets, Valeant is known for its innovative approach to drug development and patient care. The company’s core products include a diverse range of prescription medications and over-the-counter treatments, distinguished by their efficacy and unique formulations. Valeant's commitment to research and development has led to significant milestones, including strategic acquisitions that enhance its product portfolio. Recognised for its market resilience, Valeant Canada Ltd. continues to make strides in improving health outcomes while maintaining a strong competitive position in the global pharmaceutical landscape.
DitchCarbon Score
How does Valeant Canada Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Valeant Canada Ltd.'s score of 40 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Valeant Canada Ltd., headquartered in Canada, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Bausch Health Companies Inc., which means that any emissions data or climate commitments would be inherited from this parent organization. As part of its climate strategy, Bausch Health Companies Inc. has set various reduction initiatives, although specific targets for Valeant Canada Ltd. are not detailed. The company is involved in broader sustainability efforts, including participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Bausch Health Companies Inc. at a corporate family level. While Valeant Canada Ltd. does not currently report its own emissions figures, it is important to note that the company is aligned with the climate commitments and reduction strategies of its parent organization, Bausch Health Companies Inc. This alignment indicates a commitment to addressing climate change and reducing carbon footprints in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 46,686,000 | 00,000,000 |
| Scope 2 | 50,513,000 | 00,000,000 |
| Scope 3 | 19,260,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Valeant Canada Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
